Хайлтын үр дүнгүүд - Hsiaowei Deng

  • 8-н 1 - 8 үр дүнгүүдийг харуулж байна
Үр дүнг сайжруулах
  1. 1
    123I-<i>Meta</i>-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis

    123I-<i>Meta</i>-Iodobenzylguanidine Scintigraphy for the Detection of Neuroblastoma and Pheochromocytoma: Results of a Meta-Analysis -н Arnold Jacobson, Hsiaowei Deng, John Lombard, Harry J. Lessig, Richard R. Black

    Хэвлэсэн 2010
    Бүрэн текст авах
    Revisão
    Жагсаалт руу хадгалах
    -д хадгалсан:
  2. 2
    Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials

    Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials -н Vlado Perkovic, Dick de Zeeuw, Kenneth W. Mahaffey, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Terrance D. Barrett, Michele A. Weidner‐Wells, Hsiaowei Deng, David R. Matthews, Bruce Neal

    Хэвлэсэн 2018
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  3. 3
    Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (<scp>CANVAS‐R</scp>): A randomized, placebo‐controlled trial

    Rationale, design and baseline characteristics of the CANagliflozin cardioVascular Assessment Study–Renal (<scp>CANVAS‐R</scp>): A randomized, placebo‐controlled trial -н Bruce Neal, Vlado Perkovic, David R. Matthews, Kenneth W. Mahaffey, Greg Fulcher, Gary Meininger, Ngozi Erondu, Mehul Desai, Wayne Shaw, Frank Vercruysse, Jacqueline Yee, Hsiaowei Deng, Dick de Zeeuw

    Хэвлэсэн 2017
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  4. 4
    Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function

    Cardiovascular and Renal Outcomes With Canagliflozin According to Baseline Kidney Function -н Brendon L. Neuen, Toshiaki Ohkuma, Bruce Neal, David R. Matthews, Dick de Zeeuw, Kenneth W. Mahaffey, Greg Fulcher, Mehul Desai, Qiang Li, Hsiaowei Deng, Norm Rosenthal, Meg Jardine, George L. Bakris, Vlado Perkovic

    Хэвлэсэн 2018
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  5. 5
    A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial

    A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMAN... -н Mandeep R. Mehra, Muthiah Vaduganathan, Min Fu, João Pedro Ferreira, Stefan D. Anker, John G.F. Cleland, Carolyn S.P. Lam, Dirk J. van Veldhuisen, William M. Byra, Theodore E. Spiro, Hsiaowei Deng, Faı̈ez Zannad, Barry Greenberg

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  6. 6
    Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial

    Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial -н Jonathan W. Cunningham, João Pedro Ferreira, Hsiaowei Deng, Stefan D. Anker, William M. Byra, John G.F. Cleland, Mihai Gheorghiade, Carolyn S.P. Lam, David La Police, Mandeep R. Mehra, James D. Neaton, Theodore E. Spiro, Dirk J. van Veldhuisen, Barry Greenberg, Faı̈ez Zannad

    Хэвлэсэн 2020
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  7. 7
    Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm

    Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm -н Barry Greenberg, James D. Neaton, Stefan D. Anker, William M. Byra, John G.F. Cleland, Hsiaowei Deng, Min Fu, David A. La Police, Carolyn S.P. Lam, Mandeep R. Mehra, Christopher C. Nessel, Theodore E. Spiro, Dirk J. van Veldhuisen, Catherine M. Vanden Boom, Faı̈ez Zannad

    Хэвлэсэн 2019
    Бүрэн текст авах Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:
  8. 8
    Oral Factor XIa Inhibitor Milvexian After a Recent Acute Coronary Syndrome: Rationale and Design of the Phase 3 (Librexia ACS)

    Oral Factor XIa Inhibitor Milvexian After a Recent Acute Coronary Syndrome: Rationale and Design of the Phase 3 (Librexia ACS) -н C. Michael Gibson, Maria Cecilia Bahit, Roxana Mehran, Shamir R Mehta, Rasha Al Lamee, Shinya Goto, Jeffrey I. Weitz, Jay Horrow, Elliot S. Barnathan, Robert A. Harrington, Kenneth W. Mahaffey, Siniša Car, Karen S. Pieper, S. Claiborne Johnston, Graeme J. Hankey, Alexei N. Plotnikov, Danshi Li, Hsiaowei Deng, Philippe Gabríel Steg

    Хэвлэсэн 2025
    Бүрэн текст авах
    Artigo
    Жагсаалт руу хадгалах
    -д хадгалсан:

Хайх хэрэгслүүд: